Patents matching “antagonist”

US 6562978

Cyclic amine compounds as CCR5 antagonists

Takeda Chemical Industries Ltd. · Granted May 13, 2003 · Expires May 8, 2023

RU 2203884

RETINOID COMPOUNDS (VARIANTS), COMPOSITION, METHOD FOR ASSAY OF RETINOID HORMONE ANTAGONISTS, METHOD OF TREATMENT AND INTERMEDIATE SUBSTANCES

ALLERGEN SEJLZ INK [US] · Granted May 10, 2003 · Expires May 5, 2023

US 6551989

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Apr 22, 2003 · Expires Apr 17, 2023

EP 1297826

Pharmazeutische Zusammensetzung zur nasalen Verabreichung enthaltend einen NK-2 Antagonisten

MENARINI RICERCHE SPA [IT] · Granted Apr 2, 2003 · Expires Mar 28, 2023

US 6541469

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Apr 1, 2003 · Expires Mar 27, 2023

US 6537998

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Mar 25, 2003 · Expires Mar 20, 2023

US 6531475

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Mar 11, 2003 · Expires Mar 6, 2023

US 6525062

Method of treating pain using nalbuphine and opioid antagonists

The Regents of the University of California · Granted Feb 25, 2003 · Expires Feb 20, 2023

US 6514982

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Feb 4, 2003 · Expires Jan 30, 2023

US 6511811

Protein kinase C antagonist related to insulin receptor

The Regents of the University of California · Granted Jan 28, 2003 · Expires Jan 23, 2023

US 6500839

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Dec 31, 2002 · Expires Dec 26, 2022

US 6472179

Receptor based antagonists and methods of making and using

REGENERON PHARMACEUTICALS, INC. · Granted Oct 29, 2002 · Expires Oct 24, 2022

US 6440960

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Aug 27, 2002 · Expires Aug 22, 2022

US 6436966

Adenosine A3 receptor antagonists

Takeda Chemical Ind., Ltd. · Granted Aug 20, 2002 · Expires Aug 15, 2022

US 6368593

Enhanced immunogenic cell populations prepared using H2 receptor antagonists

The Regents of the University of California · Granted Apr 9, 2002 · Expires Apr 4, 2022

US 6348466

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Feb 19, 2002 · Expires Feb 14, 2022

US 6262064

Octahydrobenzo[f]quinoline-based receptor agonists and antagonists

State of Rhode Island and Providence Plantations · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6251903

Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist

The Regents of the University of California · Granted Jun 26, 2001 · Expires Jun 21, 2021

US 6221861

Reducing pyrophosphate deposition with calcium antagonists

The Regents of the University of California · Granted Apr 24, 2001 · Expires Apr 19, 2021

US 6211165

Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6211195

CRF antagonistic thiophenopyridines

Neurocrine Biosciences, Inc. · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6150325

Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions

MENARINI FARMA IND [IT] · Granted Nov 21, 2000 · Expires Nov 16, 2020

US 6147075

Alkyl, azido, alkoxy and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist

The Regents of the University of California · Granted Nov 14, 2000 · Expires Nov 9, 2020

US 6136781

LH-RH receptor antagonists

Takeda Chemical Industries Ltd. · Granted Oct 24, 2000 · Expires Oct 19, 2020